4//SEC Filing
NephroGenex, Inc. 4
Accession 0001362743-15-000003
CIK 0001338095operating
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:05 PM ET
Size
5.4 KB
Accession
0001362743-15-000003
Insider Transaction Report
Form 4
Markham Richard J
Director10% Owner
Transactions
- Award
Options to Purchase Common Stock
2015-04-30+6,870→ 6,870 totalExercise: $7.31From: 2016-04-30Exp: 2025-04-30→ Common Stock (6,870 underlying)
Footnotes (1)
- [F1]All shares underlying the options will vest on April 30, 2016 and expire 10 years from issuance.
Documents
Issuer
NephroGenex, Inc.
CIK 0001338095
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001338095
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 4:05 PM ET
- Size
- 5.4 KB